The NPB announced that they issued Japhet Amador a six-month suspension for violating their performance-enhancing drug policy.
Amador was part of a group of players that was tested at Rakuten Seimei Park on June 13, 2018. His results tested positive for chlortalidone and furosemide. The drugs are listed under WADA’s prohibited diuretics and masking agents. Amador denied intentionally taking the drugs during an interview with Rakuten personnel on July 30. His samples were retested on August 1 with no change in results.
The Rakuten Eagles notified the NPB of the results and the NPB’s Anti Doping Committee finalized their ruling on August 8.
Amador’s was given a six-month suspension (August 9, 2018 until February 8, 2019). Rakuten is currently awaiting the results of more recent tests to see if there are any changes.
The Eagles released the following statement from Amador:
I have never used performance-enhancing drugs. I have also never intentionally taken any banned substances.
I have never used stimulants or muscle enhancing agents and have never considered using diuretics or masking agents.
I have taken many tests in the past and they were all negative.
I am very surprised at the positive results from this recent test. I am concerned because I have no recollection of taking the drugs.
I am fully cooperating with investigations to discover the cause.
I apologize for worrying everyone.
[UPDATE 8/22 @ 10:40pm]
The media learned today that the Eagles filed an appeal with the NPB because they need more time to complete their investigation (today was the deadline to file). They are in the process of putting together a time line and re-testing Amador to see if they can figure out what exactly happened. The Eagles will have until September 4 to make a case.
[UPDATE 9/22 @ 11:02pm]
The NPB announced that they are going to stick to their original ruling because, bottom line, he tested positive for chlortalidone and furosemide.